Biochemical Effects of Remote Ischemic Pre-Conditioning on Contrast-induced Acute Kidney Injury
Completed · Not applicable · Has a placebo group
Conditions studied: Contrast-induced Acute Kidney Injury
In brief
This a prospective, double-blind, sham-controlled, randomized clinical trial to study the effects of remote ischemic preconditioning on acute kidney injury, vascular and renal biomarkers in patients with non-ST elevation myocardial infarction and unstable angina undergoing coronary angiography and/or percutaneous coronary intervention.
Key facts
- Study ID
- NCT03236441
- Run by
- Oladipupo Olafiranye, MD, MS
- People needed
- 110
- Starts
- 2018-03-06
- Expected to finish
- 2024-02-28
- Last updated by the study team
- 2025-01-09
Who can join
Age: 18 and older. Sex: any. Healthy volunteers: not accepted.
You may qualify if…
- Patient with non-ST elevation myocardial infarction or unstable angina
- Referral for cardiac catheterization and percutaneous coronary intervention
- Contrast-induced acute kidney injury risk score of ≥11
You may not qualify if…
- Inability to give informed consent
- unstable blood pressure (systolic blood pressure > 200 or <90 mmHg)
- History of allergy to contrast media
- Peripheral vascular disease of upper limb
- Renal disease requiring dialysis
- Placement of arteriovenous fistula and arteriovenous graft
Where it is running
- University of Pittsburgh Medical Center — Pittsburgh, Pennsylvania, United States
- VA Pittsburgh Healthcare System — Pittsburgh, Pennsylvania, United States
Full record on ClinicalTrials.gov
Trial information comes from ClinicalTrials.gov and is refreshed daily. TrialsForMe does not provide medical care and does not run the studies it lists.